Sales decline 5.24% to Rs 41.81 crore
Net profit of Jagsonpal Pharmaceuticals rose 14.69% to Rs 2.03 crore in the quarter ended September 2019 as against Rs 1.77 crore during the previous quarter ended September 2018. Sales declined 5.24% to Rs 41.81 crore in the quarter ended September 2019 as against Rs 44.12 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales41.8144.12 -5 OPM %6.035.62 -PBDT2.812.46 14 PBT2.542.21 15 NP2.031.77 15Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
